We are live on
!
Find out more
HRCM
Hood River Capital Management Portfolio holdings
AUM
$9.98B
1-Year Est. Return
145.42%
This Fund
S&P 500
This Quarter
Est. Return
+17.97%
1 Year Est. Return
+145.42%
3 Year Est. Return
+584.57%
5 Year Est. Return
+927.1%
10 Year Est. Return
+12,185.37%
AUM
$2.32B
AUM Growth
+$359M
(+18%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
4.48%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
127
New
26
Increased
45
Reduced
30
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXE
Anixter International Inc
AXE
|
+$43.1M |
| 2 |
Cogent Communications
CCOI
|
+$29.1M |
| 3 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
+$28.5M |
| 4 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
+$28.1M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
+$26.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAGE
Sage Therapeutics
SAGE
|
+$51.4M |
| 2 |
Euronet Worldwide
EEFT
|
+$33.8M |
| 3 |
MDCO
Medicines Co
MDCO
|
+$30M |
| 4 |
Innovative Industrial Properties
IIPR
|
+$26.8M |
| 5 |
FirstCash
FCFS
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.59% |
| 2 | Industrials | 24.36% |
| 3 | Technology | 23.39% |
| 4 | Financials | 6.64% |
| 5 | Consumer Discretionary | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vicor
VICR
$10.2B
| $20.3M | 0.88% |
433,766
+86,373
| +25% | +$3.29M |
|
52
Tandem Diabetes Care
TNDM
$1.56B
| $20.3M | 0.87% |
339,763
+54,552
| +19% | +$3.36M |
|
53
Grand Canyon Education
LOPE
$3.98B
| $20.2M | 0.87% |
210,470
-126,657
| -38% | -$11.7M |
|
|
WCC
54
WESCO International
WCC
$17.7B
| $19.5M | 0.84% |
+327,801
| New | +$17.1M |
|
|
AXON
55
Axon Enterprise
AXON
$46.4B
| $18.9M | 0.82% |
258,136
-202,375
| -44% | -$12.8M |
|
56
EXL Service
EXLS
$5.29B
| $18.9M | 0.82% |
1,360,520
+98,065
| +8% | +$1.34M |
|
57
Onto Innovation
ONTO
$15.3B
| $18.6M | 0.8% |
+509,835
| New | +$17.3M |
|
58
Coherus Oncology
CHRS
$196M
| $18.4M | 0.79% |
1,021,161
-16,248
| -2% | -$300K |
|
|
EVRI
59
DELISTED
Everi Holdings
EVRI
| $18M | 0.78% |
1,337,780
+22,212
| +2% | +$253K |
|
60
CoStar Group
CSGP
$12.3B
| $17.9M | 0.77% |
298,890
-286,980
| -49% | -$16.8M |
|
|
PDM
61
Piedmont Realty Trust
PDM
$1.19B
| $17.8M | 0.77% |
+802,110
| New | +$17.3M |
|
62
Kornit Digital
KRNT
$791M
| $17.8M | 0.77% |
520,629
+181,895
| +54% | +$6.03M |
|
63
Emcor
EME
$36B
| $17.4M | 0.75% |
201,607
+14,539
| +8% | +$1.28M |
|
64
KBR
KBR
$4.8B
| $16.7M | 0.72% |
+546,574
| New | +$15.4M |
|
65
MacroGenics
MGNX
$257M
| $16.4M | 0.71% |
1,505,352
+81,073
| +6% | +$803K |
|
|
SAIL
66
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $16.3M | 0.7% |
+689,718
| New | +$15.1M |
|
|
ESPR
67
DELISTED
Esperion Therapeutics
ESPR
| $16.1M | 0.7% |
+269,845
| New | +$12.1M |
|
68
PENN Entertainment
PENN
$2.71B
| $15.9M | 0.69% |
620,714
+47,284
| +8% | +$1.05M |
|
69
Freshpet
FRPT
$3.22B
| $15.9M | 0.69% |
268,390
+20,469
| +8% | +$1.09M |
|
70
Zumiez
ZUMZ
$339M
| $15.5M | 0.67% |
448,961
-35,314
| -7% | -$1.12M |
|
71
Nice
NICE
$5.97B
| $15.5M | 0.67% |
99,714
+2,127
| +2% | +$325K |
|
72
Karyopharm Therapeutics
KPTI
$48M
| $13.7M | 0.59% |
47,760
+4,357
| +10% | +$945K |
|
73
Hexcel
HXL
$7.82B
| $12.7M | 0.55% |
172,908
-163,459
| -49% | -$12.6M |
|
|
AAN.A
74
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $12.5M | 0.54% |
219,652
-150,513
| -41% | -$8.6M |
|
|
FOLD
75
DELISTED
Amicus Therapeutics
FOLD
| $12.5M | 0.54% |
+1,281,553
| New | +$11.7M |
|
Similar funds
RI
HI
MF
RA
GI
IIM
ACA
MPI
Hood River Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Hood River Capital Management held 127 positions worth $2.32B, up 18% from $1.96B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Hood River Capital Management deployed $104M of net new capital in Q4 2019, opening 26 new positions and adding to 45 existing holdings. Its largest new stake was Anixter International Inc: 531,487 shares worth $49M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was FirstCash, an estimated $25.1M trimmed.
- Hood River Capital Management's largest Q4 2019 buy was Anixter International Inc: 531,487 shares worth $49M.
- Hood River Capital Management added most to Tabula Rasa HealthCare, Inc. Common Stock in Q4 2019, an estimated $28.1M increase.
- Hood River Capital Management's biggest Q4 2019 reduction was FirstCash, cutting an estimated $25.1M.
- Hood River Capital Management fully exited Sage Therapeutics in Q4 2019, selling an estimated $51.4M.
- Hood River Capital Management's ten largest holdings make up 24% of its $2.32B portfolio in Q4 2019.
- Hood River Capital Management opened 26 new positions and closed 25 in Q4 2019.
- Hood River Capital Management's portfolio value rose 18% quarter-over-quarter to $2.32B.
Based on Hood River Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.